RAGIFILIMAB

UNII: O440IW9NHN
Preferred Substance Name: RAGIFILIMAB

2207590-51-8
AGEN1876
AGEN-1876
ANTI-GITR AGONISTIC MONOCLONAL ANTIBODY INCAGN01876
CM701
CM-701
IMMUNOGLOBULIN G1 (DE-448-LYSINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF18) (HUMAN-MUS MUSCULUS MONOCLONAL INCAGN01876.GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL INCAGN01876 .KAPPA.-CHAIN, DIMER
INCAGN01876
INCAGN-01876
RAGIFILIMAB [INN]
RAGIFILIMAB [USAN]
RAGIFILIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

RAGIFILIMAB

Synonyms and Mappings

Resources

Note